Nestlé May Shed Peanut Allergy Treatment as Sales Disappoint

Malaysia News News

Nestlé May Shed Peanut Allergy Treatment as Sales Disappoint
Malaysia Latest News,Malaysia Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

Nestle said it would explore options for Palforzia. Although it is the world's only approved peanut allergy drug, it has so far proved a flop.

Nestlé SA said Tuesday it would explore strategic options for the treatment, effectively putting the drug up for sale, following lower-than-expected demand from doctors and patients. The move comes just two years after the packaged-food giant agreed to.

Nestlé SA said Tuesday it would explore strategic options for the treatment, effectively putting the drug up for sale, following lower-than-expected demand from doctors and patients. The move comes just two years after the packaged-food giant agreed to
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Breakingviews - Nestlé U-turn is refreshing example of M&A candourBreakingviews - Nestlé U-turn is refreshing example of M&A candourIt’s common for companies to do a bad deal. It’s less common for them to admit as much and reverse tack after just two years. That’s what Nestlé is potentially doing by deciding to “explore strategic options” for Palforzia, which could mean selling the peanut allergy treatment that it bagged as part of a $2.6 billion acquisition of Aimmune Therapeutics, announced in August 2020. Nestlé originally touted potential annual sales of $1 billion for the drug, which had received U.S. Food and Drug Administration approval. But on Tuesday the Swiss consumer-goods giant said uptake had been slow among patients and doctors.
Read more »

Scooplet: Nestlé to debut plant-based chocolate chipsScooplet: Nestlé to debut plant-based chocolate chipsPlant-based Toll House morsels will likely hit shelves in 2023.
Read more »

Production Lamps Shed Light On How Production Audi A6 E-Tron Will Look | CarscoopsProduction Lamps Shed Light On How Production Audi A6 E-Tron Will Look | Carscoops carscoops
Read more »

Surprising Findings – New Samples Shed Light on the Moon’s History and MakeupSurprising Findings – New Samples Shed Light on the Moon’s History and MakeupThe new study analyzed soil samples brought back from the Chang'E-5 mission. According to a study that examined soil samples returned as part of the Chang'E - 5 (CE-5) mission in 2020, the active volcanic activity helped create the moon's surface mineralogy as recently as 2 billion years ago, leavi
Read more »

Audi R8 GT: Saving the Best For LastAudi R8 GT: Saving the Best For LastThe irony that to build the best R8 ever, Audi shed its defining characteristic.
Read more »

Audi R8 GT: Saving the Best For LastAudi R8 GT: Saving the Best For LastThe irony that to build the best R8 ever, Audi shed its defining characteristic.
Read more »



Render Time: 2025-03-01 08:00:03